Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | Global End Stage Renal Disease (ESRD) Market: Size, Trends and Forecasts (2016-2020)The Global End Stage Renal Disease (ESRD) Market report provides detailed market share analysis of the global dialysis market by players as well.
By: Daedal Research The report also includes the country analysis of the U.S. and Japan for ESRD market. It provides the analysis of ESRD patient volume along with the kidney transplant and dialysis market on the basis of the volume. The segments of the dialysis market are also analyzed in detail. The report provides detailed regional analysis of North America, Europe, Meddle East and Africa (EMEA), Asia-Pacific and Latin America for the dialysis market. Regional analysis includes market size by volume along with the segments and clinic operators in each region. Furthermore, the report assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global ESRD market has also been forecasted for the period 2016-2020, taking into consideration the previous growth patterns, the growth drivers and the current and future trends. The competition in the global dialysis market is stiff and dominated by the big players like FMC. Further, key players of the dialysis market Baxter and Davita are also profiled with their financial information and respective business strategies. Regional Coverage - North America - EMEA - Asia-Pacific - Latin America Country Coverage - The U.S. - Japan Company Coverage - Fresenius Medical Care - Baxter International - Davita Healthcare Partners Executive Summary End Stage renal disease (ESRD) occurs when the kidneys are no longer able to carry out their daily functions, requiring either dialysis or transplantation to sustain life. When properly functioning, kidneys act to filter the body of metabolic wastes, which are excreted as urine, and to maintain fluid balance. Chronic kidney failure, a decline in kidney function most often related to diabetes or hypertension, but resulting from other causes as well, including vascular disease, genetic disorders, and exposure to toxic levels of certain drugs. The best strategy for preventing ESRD is to detect chronic kidney failure at the earliest possible stage so that the decline in kidney function can be slowed through the use of medications and tight control of blood sugar and blood pressure levels. The global ESRD market increased at a significant CAGR during the span of 5 years, i.e. 2010-2015 and projections are made that the market would rise in the next five years i.e. 2016-2020 tremendously. The upsurge in the market was due to the various reasons such as is diabetic nephropathy, genetic diseases, infection, drugs, traumatic injury, major surgery and etc. The market can be segmented on the basis of treatment as kidney transplant and dialysis. The global dialysis market can be segmented on the basis of products and services. On the basis of products, the market is segmented into hemodialysis and peritoneal dialysis while on the basis of services, the market is segmented into in-center dialysis and home dialysis. The growth drivers for the market are: rise in diabetic and aging population, upsurge in per capita healthcare expenditure along with the emerging countries such as India, China and Brazil. Despite the market is governed by various growth drivers, there are certain challenges faced by the market such as: disparities in the access to renal transplant therapy, less public awareness and negative societal effects. List of Figures: Figure 1: Treatments of ESRD Figure 2: Types of Dialysis Treatments Figure 3: Global ESRD Market by Volume; 2010-2015 (Million) Figure 4: Global ESRD Market by Volume; 2016E-2020E (Million) Figure 5: Global ESRD Prevalence Rate; 2010-2015E (p.m.p) Figure 6: Global ESRD Market by Segments; 2015 (%) Figure 7: The U.S. ESRD Market by Volume; 2010-2015E (Thousand) Figure 8: The U.S. ESRD Prevalence Rate; 2010-2015E (p.m.p) Figure 9: The U.S. ESRD Market by Causes of Disease; 2013-2015E (%) Figure 10: Japan ESRD Market by Volume; 2010-2015E (Thousand) Figure 11: Japan ESRD Market by Segments; 2013-2015E (%) Figure 12: Global Kidney Transplant Market by Volume; 2010-2016E (Thousand) Figure 13: The U.S. Kidney Transplant Market by Volume; 2010-2015E (Thousand) Figure 14: Japan Kidney Transplant Market by Volume; 2010-2015E (Thousand) Figure 15: Global Dialysis Market by Value; 2014-2020E (US$ Billion) Figure 16: Global Dialysis Market by Volume; 2010-2016E (Million) Figure 17: Global Dialysis Market by Segments on the Basis of Products; 2015 (%) Figure 18: Global Hemodialysis Market by Volume; 2010-2015 (Million) Figure 19: Global Peritoneal Dialysis Market by Volume; 2010-2015 (Thousand) Figure 20: Global Dialysis Market by Segments on the Basis of Services; 2014 (%) Figure 21: Global Dialysis Prevalence Rate; 2010-2015E (p.m.p) Figure 22: Global Dialysis Market by Region; 2015 (%) Figure 23: North America Dialysis Market by Volume; 2010-2015 (Thousand) Figure 24: The U.S. Dialysis Market by Volume; 2010-2015E (Thousand) Figure 25: The U.S. Hemodialysis Market by Volume; 2010-2015E (Thousand) Figure 26: The U.S. Peritoneal Dialysis Market by Volume; 2010-2015E (Thousand) Figure 27: EMEA Dialysis Market by Volume; 2010-2015 (Thousand) For further details, kindly visit : http://www.daedal- Rajeev Kumar (Business Development Manager) Address: 36 SFS Flats Paschim Vihar New Delhi-110063 Mobile: +91-8743975789 Tel: +91-120-4553017 Mail ID - info@daedal- Daedal Research is a research and consulting firm specialized in providing research reports and customized business research and analysis. For more Information: http://www.daedal- End
| ||||||||||||||||||||||||||||||||||||||||||||||||
Account Phone Number